Parra, Rogério Serafim 
; Ferreira, Sandro da Costa ; Machado, Vanessa Foresto; Nigro, Cintia Maura Caseiro ; Rocha, José Joaquim Ribeiro da ; Troncon, Luiz Ernesto de Almeida ; Féres, Omar
Source: Journal of Clinical Medicine. Unidade: FMRP
Subjects: INFLAMAÇÃO, ENTEROPATIAS INFLAMATÓRIAS, COLITE ULCERATIVA, DOENÇA DE CROHN, TERAPIA BIOLÓGICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PARRA, Rogério Serafim et al. Access to high-cost biological agents: perceptions of Brazilian patients with inflammatory bowel diseases. Journal of Clinical Medicine, v. 12, p. 1-11, 2023Tradução . . Disponível em: https://doi.org/10.3390/jcm12072672. Acesso em: 06 jan. 2026.APA
Parra, R. S., Ferreira, S. da C., Machado, V. F., Nigro, C. M. C., Rocha, J. J. R. da, Troncon, L. E. de A., & Féres, O. (2023). Access to high-cost biological agents: perceptions of Brazilian patients with inflammatory bowel diseases. Journal of Clinical Medicine, 12, 1-11. doi:10.3390/jcm12072672NLM
Parra RS, Ferreira S da C, Machado VF, Nigro CMC, Rocha JJR da, Troncon LE de A, Féres O. Access to high-cost biological agents: perceptions of Brazilian patients with inflammatory bowel diseases [Internet]. Journal of Clinical Medicine. 2023 ; 12 1-11.[citado 2026 jan. 06 ] Available from: https://doi.org/10.3390/jcm12072672Vancouver
Parra RS, Ferreira S da C, Machado VF, Nigro CMC, Rocha JJR da, Troncon LE de A, Féres O. Access to high-cost biological agents: perceptions of Brazilian patients with inflammatory bowel diseases [Internet]. Journal of Clinical Medicine. 2023 ; 12 1-11.[citado 2026 jan. 06 ] Available from: https://doi.org/10.3390/jcm12072672
